RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ARCANGELI V
Collezione AOU Città della Salute di Torino

Items : 7

Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management. in Cancer medicine / Cancer Med. 2024 Aug;13(16):e70114. doi: 10.1002/cam4.70114.

2024
AOU Città della Salute di Torino

Innella G; Fortuno C; Caleca L; Feng BJ; Carroll C; Parsons MT; Miccoli S; Montagna M; Calistri D; Cortesi L; Pasini B; Manoukian S; Giachino D; Matricardi L; Foti MC; Zampiga V; Piombino C; Barbieri E; Lutati FV; Azzolini J; Danesi R; Arcangeli V; Caputo SM; Boutry-Kryza N; Goussot V; Hiraki S; Richardson M; Ferrari S; Radice P; et alii...

Intracranial complications of sinogenic and otogenic infections in children: an ESPN survey on their occurrence in the pre-COVID and post-COVID era. in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery / Childs Nerv Syst. 2024 Apr;40(4):1221-1237. doi: 10.1007/s00381-024-06332-9. Epub 2024 Mar 8.

2024
AOU Città della Salute di Torino

Massimi L; Cinalli G; Frassanito P; Arcangeli V; Auer C; Baro V; Bartoli A; Bianchi F; Dietvorst S; Di Rocco F; Gallo P; Giordano F; Hinojosa J; Iglesias S; Jecko V; Kahilogullari G; Knerlich-Lukoschus F; Laera R; Locatelli D; Luglietto D; Luzi M; Messing-Jünger M; Mura R; Ragazzi P; Riffaud L; Roth J; Sagarribay A; Pinheiro MS; Spazzapan P; et alii...

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. in British journal of cancer / Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.

2023
AOU Città della Salute di Torino
ASL Vercelli

Aglietta M; Arcangeli V; Benedetti Panici P; De Giorgi U; Zola P; Rubio-Pérez MJ; DeCensi A; Tognon G; Pardo B; Romeo M; Tasca G; Funari G; Iglesias M; Biagioli E; Mirza MR; Deryal M; Fossati R; Barretina-Ginesta MP; Herbertson R; Riniker S; Nyvang GB; Chekerov R; Churruca Galaz C; D'Incalci M; Vergote I; Berger R; Ottevanger NB; Montes A; Sessa C; et alii...

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Oct 2;9(77):34639-34640. doi: 10.18632/oncotarget.26213. eCollection 2018 Oct 2.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Fabi A; Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Artale S; Blasi L; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; Ficorella C; Moretti G; Airoldi M; Sartori D; Valerio MR; Fumagalli A; Ciccarese M; Verusio C; et alii...

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431. eCollection 2018 Nov 30.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Aug 7;9(61):31877-31887. doi: 10.18632/oncotarget.25874. eCollection 2018 Aug 7.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Blasi L; Artale S; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; Ficorella C; Moretti G; Airoldi M; Ancona C; Valerio MR; Sartori D; Fumagalli A; Ciccarese M; Verusio C; et alii...

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. in Breast (Edinburgh, Scotland) / Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.

2017
ASL Città di Torino
AOU Città della Salute di Torino

Sartori D; Scavelli C; Porpiglia M; Pistelli M; Palumbo R; Musolino A; Moretti G; Michelotti A; Maur M; La Verde N; Generali D; Gebbia V; Garrone O; Frassoldati A; Fumagalli A; Ficorella C; Ferzi A; Ferrari L; Fabi A; Piezzo M; Cursano MC; Ciccarese M; Campidoglio S; Blasi L; Bianchi GV; Ballerio A; Atzori F; Artale S; Arcangeli V; et alii...